Importer of Controlled Substances Application: Groff NA Hemplex LLC, 101051-101052 [2024-29343]
Download as PDF
101051
Federal Register / Vol. 89, No. 240 / Friday, December 13, 2024 / Notices
hearing on October 3, 2024. All persons
who requested the opportunity were
permitted to participate.
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on December 10, 2024.
The views of the Commission are
contained in USITC Publication 5565
(December 2024), entitled Steel
Concrete Reinforcing Bar from Belarus,
China, Indonesia, Latvia, Moldova,
Poland, Ukraine: Investigation Nos.
731–TA–873–875, 878–880, and 882
(Fourth Review).
individuals must contact the office
listed above by 5 p.m. (eastern time) on
December 31, 2024. After this deadline,
only remote observation is permitted.
Remote registration is available until the
meeting date, provided it is completed
before the projected end time.
The announcement for this hearing
was previously published in the Federal
Register on October 28, 2024 at 89 FR
85557.
(Authority: 28 U.S.C. 2073.)
Controlled substance
Dated: December 9, 2024.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
[FR Doc. 2024–29330 Filed 12–12–24; 8:45 am]
By order of the Commission.
Issued: December 10, 2024.
Lisa Barton,
Secretary to the Commission.
BILLING CODE 2210–55–P
DEPARTMENT OF JUSTICE
[FR Doc. 2024–29441 Filed 12–12–24; 8:45 am]
Drug Enforcement Administration
BILLING CODE 7020–02–P
[Docket No. DEA–1459]
JUDICIAL CONFERENCE OF THE
UNITED STATES
Bulk Manufacturer of Controlled
Substances Application: National
Center for Natural Products Research
Committee on Rules of Practice and
Procedure; Meeting of the Judicial
Conference
Judicial Conference of the
United States.
ACTION: Committee on Rules of Practice
and Procedure; revised notice of open
meeting.
The Committee on Rules of
Practice and Procedure will hold a
meeting in a hybrid format with remote
attendance options on January 7, 2025
in San Diego, CA as previously
announced. The meeting is open to the
public for observation but not
participation. Please see the
Supplementary Information section in
this notice for instructions on observing
the meeting.
DATES: January 7, 2025 (meeting date)
and December 31, 2024 (registration
deadline for in person observation).
ADDRESSES: An agenda and supporting
materials will be posted at least 7 days
in advance of the meeting at: https://
www.uscourts.gov/rules-policies/
records-and-archives-rules-committees/
agenda-books.
FOR FURTHER INFORMATION CONTACT: H.
Thomas Byron III, Esq., Chief Counsel,
Rules Committee Staff, Administrative
Office of the U.S. Courts, Thurgood
Marshall Federal Judiciary Building,
One Columbus Circle NE, Suite 7–300,
Washington, DC 20544, Phone (202)
502–1820, RulesCommittee_Secretary@
ao.uscourts.gov.
SUPPLEMENTARY INFORMATION: To
observe the meeting in person,
khammond on DSK9W7S144PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:17 Dec 12, 2024
Jkt 265001
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
AGENCY:
National Center for Natural
Products Research has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before February 11, 2025. Such
persons may also file a written request
for a hearing on the application on or
before February 11, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUMMARY:
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 5, 2024,
National Center for Natural Products
Research, Coy Waller Research Center,
806 Hathorn Road, University,
Mississippi 38677–1848 applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Marihuana Extract .........
Marihuana ......................
Tetrahydrocannabinols ..
Drug
code
7350
7360
7370
Schedule
I
I
I
The company plans to manufacture
the listed controlled substances for
product development and reference
standards. In reference to drug codes
7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to isolate these controlled
substances from procured 7350
(Marihuana Extract). In reference to
drug code 7360, no cultivation activities
are authorized for this registration. No
other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–29341 Filed 12–12–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1451]
Importer of Controlled Substances
Application: Groff NA Hemplex LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Groff NA Hemplex LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 13, 2025. Such
persons may also file a written request
for a hearing on the application on or
before January 13, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
SUMMARY:
E:\FR\FM\13DEN1.SGM
13DEN1
101052
Federal Register / Vol. 89, No. 240 / Friday, December 13, 2024 / Notices
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on September 30, 2024,
Groff NA Hemplex LLC, 2218 South
Queen Street, York, Pennsylvania
17402, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
khammond on DSK9W7S144PROD with NOTICES
Marihuana Extract .........
Marihuana ......................
Tetrahydrocannabinols ..
Drug
code
7350
7360
7370
Schedule
I
I
I
The company plans to import the
listed controlled substances in bulk
form to manufacture research grade
material for clinical trial studies.
Several types of Marihuana Extract
compounds are listed under drug code
7350. No other activities for these drug
codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–29343 Filed 12–12–24; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
18:17 Dec 12, 2024
Jkt 265001
DEPARTMENT OF LABOR
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Reports of
Injuries to Employees Operating
Mechanical Power Presses
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this Occupational
Safety & Health Administration (OSHA)sponsored information collection
request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that the agency
receives on or before January 13, 2025.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Nicole Bouchet by telephone at 202–
693–0213, or by email at DOL_PRA_
PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: In the
event an employee is injured while
operating a mechanical power press, 29
CFR 1910.217(g) requires an employer
to provide information to OSHA
regarding the accident. This information
includes the employer’s and employee’s
name, the type of clutch, the type of
safeguard(s) used, the cause of the
accident, the means to actuate the press
stroke, and the number of operators
involved. For additional substantive
information about this ICR, see the
related notice published in the Federal
Register on June 7, 2024 (89 FR 48691).
Comments are invited on: (1) whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) the accuracy of
the agency’s estimates of the burden and
cost of the collection of information,
including the validity of the
methodology and assumptions used; (3)
ways to enhance the quality, utility and
clarity of the information collection; and
(4) ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
SUMMARY:
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
automated collection techniques or
other forms of information technology.
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless the OMB
approves it and displays a currently
valid OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOL notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Agency: DOL–OSHA.
Title of Collection: Reports of Injuries
to Employees Operating Mechanical
Power Presses.
OMB Control Number: 1218–0070.
Affected Public: Private Sector—
Businesses or other for-profits.
Total Estimated Number of
Respondents: 960.
Total Estimated Number of
Responses: 1,920.
Total Estimated Annual Time Burden:
320 hours.
Total Estimated Annual Other Costs
Burden: $0.
(Authority: 44 U.S.C. 3507(a)(1)(D))
Nicole Bouchet,
Senior Paperwork Reduction Act Analyst.
[FR Doc. 2024–29339 Filed 12–12–24; 8:45 am]
BILLING CODE 4510–26–P
NATIONAL CREDIT UNION
ADMINISTRATION
Revision of Agency Information
Collection of a Previously Approved
Collection; Request for Comments
National Credit Union
Administration (NCUA).
ACTION: Notice of submission to the
Office of Management and Budget.
AGENCY:
As required by the Paperwork
Reduction Act of 1995, The National
Credit Union Administration (NCUA) is
submitting the following extensions and
revisions of currently approved
collections to the Office of Management
and Budget (OMB) for renewal.
DATES: Written comments should be
received on or before January 13, 2025
to be assured consideration.
SUMMARY:
E:\FR\FM\13DEN1.SGM
13DEN1
Agencies
[Federal Register Volume 89, Number 240 (Friday, December 13, 2024)]
[Notices]
[Pages 101051-101052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29343]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1451]
Importer of Controlled Substances Application: Groff NA Hemplex
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Groff NA Hemplex LLC has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
January 13, 2025. Such persons may also file a written request for a
hearing on the application on or before January 13, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal,
[[Page 101052]]
which provides the ability to type short comments directly into the
comment field on the web page or attach a file for lengthier comments.
Please go to https://www.regulations.gov and follow the online
instructions at that site for submitting comments. Upon submission of
your comment, you will receive a Comment Tracking Number. Please be
aware that submitted comments are not instantaneously available for
public view on https://www.regulations.gov. If you have received a
Comment Tracking Number, your comment has been successfully submitted
and there is no need to resubmit the same comment. All requests for a
hearing must be sent to: (1) Drug Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement Administration, Attn: DEA Federal
Register Representative/DPW, 8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a hearing should also be sent to: Drug
Enforcement Administration, Attn: Administrator, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on September 30, 2024, Groff NA Hemplex LLC, 2218 South
Queen Street, York, Pennsylvania 17402, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
bulk form to manufacture research grade material for clinical trial
studies. Several types of Marihuana Extract compounds are listed under
drug code 7350. No other activities for these drug codes are authorized
for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-29343 Filed 12-12-24; 8:45 am]
BILLING CODE P